[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2021 US HIV/AIDS Diagnostics Market Assessment: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

April 2021 | 60 pages | ID: 24352A7C7FE4EN
Venture Planning Group

US$ 1,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.

The report is available by section, and can be customized to specific information needs and budget.

This report presents the US test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Blood Banks
  • Public Health Labs
  • Physician Offices
The DataPack provides sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche.

Contains 60 pages and 7 tables
Major Companies Developing or Marketing AIDS Tests
USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
USA: HIV Ag Test Volume and Sales Forecast by Market Segment
USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers


More Publications